72509-76-3 | 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$6.00	$4.00
10mg	98%	in stock	$8.00	$6.00
50mg	98%	in stock	$12.00	$9.00
1g	98%	in stock	$26.00	$18.00
5g	98%	in stock	$50.00	$35.00
10g	98%	in stock	$84.00	$59.00
25g	98%	in stock	$166.00	$117.00
100g	98%	in stock	$403.00	$282.00

Description

• Catalog Number: AC70128
• Chemical Name: 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
• CAS Number: 72509-76-3
• Molecular Formula: C18H19Cl2NO4
• Molecular Weight: 384.2538
• MDL Number: MFCD00868316
• SMILES: CCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1Cl)Cl)C(=O)OC)C
• NSC Number: 760343

Computed Properties

• Complexity: 614
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 25
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 6
• Undefined Atom Stereocenter Count: 1
• XLogP3: 3.9

Literature

• In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding.

  Toxicology in vitro : an international journal published in association with BIBRA 20170401

• Differential modulation of FXR activity by chlorophacinone and ivermectin analogs.

  Toxicology and applied pharmacology 20161215

• Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450.

  Toxicology letters 20161116

• Transactivation Assays to Assess Canine and Rodent Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) Activation.

  PloS one 20160101

• Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor.

  Scientific reports 20140101

• Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).

  Toxicological sciences : an official journal of the Society of Toxicology 20131201

• Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20131001

• Felodipine-diazabicyclo[2.2.2]octane-water (1/1/1).

  Acta crystallographica. Section C, Crystal structure communications 20121101

• Antihypertensive effect of low-frequency transcutaneous electrical nerve stimulation (TENS) in comparison with drug treatment.

  Blood pressure 20121001

• Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120901

• Mechanistic insights into the dissolution of spray-dried amorphous solid dispersions.

  Journal of pharmaceutical sciences 20120801

• QSAR model for human pregnane X receptor (PXR) binding: screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity.

  Toxicology and applied pharmacology 20120801

• A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model.

  The AAPS journal 20120601

• Moringa coagulant as a stabilizer for amorphous solids: Part I.

  AAPS PharmSciTech 20120601

• Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

  Journal of medicinal chemistry 20120524

• Microstructural investigation to the controlled release kinetics of monolith osmotic pump tablets via synchrotron radiation X-ray microtomography.

  International journal of pharmaceutics 20120510

• Enhancement of felodipine dissolution rate through its incorporation into Eudragit® E-PHB polymeric microparticles: in vitro characterization and investigation of absorption in rats.

  Journal of pharmaceutical sciences 20120401

• Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.

  European journal of clinical investigation 20120301

• ToF-SIMS analysis of chemical heterogenities in inkjet micro-array printed drug/polymer formulations.

  Journal of materials science. Materials in medicine 20120201

• [Analysis and evaluation of the impurity of felodipine and its tablets].

  Yao xue xue bao = Acta pharmaceutica Sinica 20120201

• Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.

  Bioorganic & medicinal chemistry letters 20120115

• Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization.

  Pharmaceutical development and technology 20120101

• Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension.

  Journal of hypertension 20120101

• Inkjet printing as a novel medicine formulation technique.

  Journal of controlled release : official journal of the Controlled Release Society 20111210

• Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma.

  Investigational new drugs 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Compositional analysis of low quantities of phase separation in hot-melt-extruded solid dispersions: a combined atomic force microscopy, photothermal fourier-transform infrared microspectroscopy, and localised thermal analysis approach.

  Pharmaceutical research 20110901

• Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

  AAPS PharmSciTech 20110901

• Development of a high-performance liquid chromatography method for simultaneous determination of pioglitazone and felodipine in pig serum: application to pharmacokinetic study.

  Biomedical chromatography : BMC 20110801

• Dissolution and precipitation behavior of amorphous solid dispersions.

  Journal of pharmaceutical sciences 20110801

• The stability of solid dispersions of felodipine in polyvinylpyrrolidone characterized by nanothermal analysis.

  International journal of pharmaceutics 20110729

• Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization.

  Drug delivery 20110701

• Influence of particle size on the ultraviolet spectrum of particulate-containing solutions: implications for in-situ concentration monitoring using UV/Vis fiber-optic probes.

  Pharmaceutical research 20110701

• Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals.

  Microvascular research 20110701

• The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome.

  Microvascular research 20110701

• Cystic fibrosis: a new target for 4-Imidazo[2,1-b]thiazole-1,4-dihydropyridines.

  Journal of medicinal chemistry 20110609

• Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.

  European heart journal 20110601

• A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.

  Bioorganic & medicinal chemistry letters 20110515

• Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer.

  AAPS PharmSciTech 20110301

• Identification of clinically used drugs that activate pregnane X receptors.

  Drug metabolism and disposition: the biological fate of chemicals 20110101

• Pharmacokinetics of felodipine extended-release tablets in healthy Taiwanese subjects: a retrospective review.

  Arzneimittel-Forschung 20110101

• [Calcium channels blocker felodipin in the treatment of patients with arterial hypertension and chronic cardial failure with preserved cardiac output].

  Terapevticheskii arkhiv 20110101

• Pharmacokinetic and antihypertensive profile of amlodipine and felodipine-ER in younger versus older patients with hypertension.

  Journal of cardiovascular pharmacology 20101201

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• [Therapeutic effect on essential hypertension treated with combined therapy of acupuncture and medication].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20101101

• A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions.

  International journal of pharmaceutics 20101031

• Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study.

  Journal of hypertension 20101001

• Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility.

  Pharmaceutical research 20101001

• Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values.

  European journal of medicinal chemistry 20101001

• Characterisation and prediction of phase separation in hot-melt extruded solid dispersions: a thermal, microscopic and NMR relaxometry study.

  Pharmaceutical research 20100901

• A novel method to measure the glass and melting transitions of pharmaceutical powders.

  International journal of pharmaceutics 20100830

• [Effect between felodipine plus irbesartan and felodipine plus metoprolol regimen on the sexual function in young and middle-aged women with hypertension].

  Zhonghua xin xue guan bing za zhi 20100801

• Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation.

  Drug metabolism and disposition: the biological fate of chemicals 20100601

• Effect of felodipine on myocardial and renal injury induced by aldosterone-high salt hypertension in uninephrectomized rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100501

• Publication bias on clinical studies of pharmacokinetic interactions between felodipine and grapefruit juice.

  Die Pharmazie 20100501

• Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.

  Molecular pharmaceutics 20100405

• Understanding the behavior of amorphous pharmaceutical systems during dissolution.

  Pharmaceutical research 20100401

• Blockade of calcium channels and AT1 receptor prevents the hypertensive effect of calcilytic NPS 2143 in rats.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100401

• A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

  Proceedings of the National Academy of Sciences of the United States of America 20100223

• Interaction between felodipine and bovine serum albumin: fluorescence quenching study.

  Luminescence : the journal of biological and chemical luminescence 20100101

• Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).

  Journal of pharmaceutical sciences 20100101

• Felodipine-induced eruptive telangiectasia following mastectomy and radiotherapy.

  The British journal of dermatology 20100101

• [Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension].

  Lijecnicki vjesnik 20100101

• [Calcium antagonists: on the way to expanding the indications].

  Terapevticheskii arkhiv 20100101

• [Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].

  Kardiologiia 20100101

• Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.

  PloS one 20100101

• Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.

  Pharmaceutical research 20091201

• Synthesis of 4-thiophen-2'-yl-1,4-dihydropyridines as potentiators of the CFTR chloride channel.

  Bioorganic & medicinal chemistry 20091201

• Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

  Pharmaceutical research 20091101

• [Impact of antihypertensive medication timing on degree and stability of blood pressure lowering in patients with essential hypertension].

  Zhonghua xin xue guan bing za zhi 20091101

• Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.

  Bioorganic & medicinal chemistry 20091001

• Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

  Nature chemical biology 20091001

• Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

  The Journal of pharmacology and experimental therapeutics 20090901

• [Effect of felodipine on the expression of NF-kappaB in rat model of atherosclerosis].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20090901

• Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens.

  Die Pharmazie 20090801

• Preparation of N-maleoylchitosan nanocapsules for loading and sustained release of felodipine.

  Biomacromolecules 20090713

• Extended release felodipine self-nanoemulsifying system.

  AAPS PharmSciTech 20090601

• Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090512

• Pair distribution function X-ray analysis explains dissolution characteristics of felodipine melt extrusion products.

  Journal of pharmaceutical sciences 20090401

• Felodipine downregulates serum interleukin-18 levels in rats with fructose-induced metabolic syndrome.

  Journal of endocrinological investigation 20090401

• The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.

  International journal of cardiology 20090220

• Chloride channels as drug targets.

  Nature reviews. Drug discovery 20090201

• [The use of felodipine in ambulatory practice: assessment of clinical efficacy and compliance in patients with arterial hypertension].

  Kardiologiia 20090101

• A cell-based assay for screening of antidotes to, and antivenom against Chironex fleckeri (box jellyfish) venom.

  Journal of pharmacological and toxicological methods 20090101

• From Tritace to Tri-Plen - the South African journey.

  Cardiovascular journal of Africa 20090101

• [Structural-functional properties of the vascular wall in hypertensive patients with coronary heart disease: effects of felodipin and perindopril].

  Terapevticheskii arkhiv 20090101

• Vasospasm-induced polymorphic ventricular tachycardia.

  The Canadian journal of cardiology 20081201

• Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.

  Blood pressure. Supplement 20081201

• [Curative effects on mild to moderate primary hypertension and influence on pulse wave velocity of slow releasing felodipine].

  Zhonghua yi xue za zhi 20081118

• Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

  Journal of medicinal chemistry 20081113

• Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

  Journal of medicinal chemistry 20081009

• Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081001

• Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-kappaB activation.

  Acta pharmacologica Sinica 20080901

• Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.

  Archives of pharmacal research 20080801

• Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.

  The Journal of biological chemistry 20080620

• Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

  Journal of medicinal chemistry 20080612

• Effect and tolerability of felodipine ER (Feloten) in the treatment of hypertension assessed by office blood pressure and home blood pressure.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080501

• Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.

  Pharmaceutical research 20080401

• Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.

  Pharmaceutical research 20080301

• Application of a self-modeling curve resolution method for studying the photodegradation kinetics of nitrendipine and felodipine.

  Journal of pharmaceutical and biomedical analysis 20080213

• Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells.

  Toxicology 20080203

• Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.

  Journal of cardiovascular pharmacology 20080201

• Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension.

  Clinical chemistry and laboratory medicine 20080101

• Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats.

  Molecular medicine (Cambridge, Mass.) 20080101

• [Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension].

  Kardiologiia 20080101

• [Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20071218

• Calorimetric study and modeling of molecular mobility in amorphous organic pharmaceutical compounds using a modified Adam-Gibbs approach.

  The journal of physical chemistry. B 20071122

• [Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits].

  Yao xue xue bao = Acta pharmaceutica Sinica 20071101

• The influence of hydro-alcoholic media on hypromellose matrix systems.

  Drug development and industrial pharmacy 20071001

• Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth.

  Langmuir : the ACS journal of surfaces and colloids 20070911

• Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.

  The Journal of pharmacology and experimental therapeutics 20070801

• Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.

  International journal of pharmaceutics 20070801

• Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine.

  Current drug metabolism 20070801

• Simultaneous determination of nitrendipine and one of its metabolites in plasma samples by gas chromatography with electron-capture detection.

  Journal of pharmaceutical and biomedical analysis 20070727

• Structure-activity relationship of 1,4-dihydropyridines as potentiators of the cystic fibrosis transmembrane conductance regulator chloride channel.

  Molecular pharmacology 20070701

• Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070601

• The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070501

• Estimation of intragastric solubility of drugs: in what medium?

  Pharmaceutical research 20070501

• Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.

  Circulation 20070417

• Determination of gambogic acid in dog plasma by high-performance liquid chromatography for a pharmacokinetic study.

  Biomedical chromatography : BMC 20070301

• Lercanidipine in the treatment of hypertension.

  The Annals of pharmacotherapy 20070301

• The in vitro vascular effects of two chirodropid (Chironex fleckeri and Chiropsella bronzie) venoms.

  Toxicology letters 20070110

• Photophysics and photochemical studies of 1,4-dihydropyridine derivatives.

  Photochemistry and photobiology 20070101

• [The FEVER (Felodipine EVEnt Reduction) trial; a randomised, double-blind, placebo-controlled trial in Chinese hypertensive patients].

  Vnitrni lekarstvi 20070101

• Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug.

  Medicina (Kaunas, Lithuania) 20070101

• [Effects of serotonin on reactivity of ocular vasculature].

  Oftalmologia (Bucharest, Romania : 1990) 20070101

• Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.

  Journal of pharmaceutical sciences 20061201

• Preparation of a solid dispersion of felodipine using a solvent wetting method.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20061001

• A comparison of the physical stability of amorphous felodipine and nifedipine systems.

  Pharmaceutical research 20061001

• Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.

  Pharmaceutical research 20061001

• Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.

  Clinical and experimental hypertension (New York, N.Y. : 1993) 20061001

• Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.

  International journal of pharmaceutics 20060817

• Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060801

• Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060601

• FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines.

  Journal of hypertension 20060601

• A small-molecule screen in C. elegans yields a new calcium channel antagonist.

  Nature 20060504

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Micronization and microencapsulation of felodipine by supercritical carbon dioxide.

  Journal of microencapsulation 20060501

• Effect of grapefruit juice in relation to human pharmacokinetic study.

  Current clinical pharmacology 20060501

• Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer.

  International journal of pharmaceutics 20060426

• Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy.

  Hypertension (Dallas, Tex. : 1979) 20060401

• A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).

  American journal of hypertension 20060401

• CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension.

  Pharmacogenomics 20060401

• Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter?

  International journal of clinical practice 20060301

• AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women.

  Maturitas 20060120

• Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.

  Journal of hypertension 20060101

• Hypertensive urgency.

  Journal of clinical hypertension (Greenwich, Conn.) 20060101

• Comparative study of barnidipine and felodipine in Chinese patients with essential hypertension.

  The Journal of international medical research 20060101

• A review of calcium channel antagonists in the treatment of pediatric hypertension.

  Paediatric drugs 20060101

• Thermal stability of 1,4-dihydropyridine derivatives in solid state.

  Acta poloniae pharmaceutica 20060101

• More heat to support aggressive blood pressure lowering: the FEVER study.

  Journal of hypertension 20051201

• The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

  Journal of hypertension 20051201

• Calcium channel antagonists and inhibition of human sphincter of Oddi contractions.

  Scandinavian journal of gastroenterology 20051201

• Impact of the intragastric location of extended release tablets on food interactions.

  Journal of controlled release : official journal of the Controlled Release Society 20051128

• Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.

  American journal of hypertension 20051001

• Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.

  Bioorganic & medicinal chemistry letters 20050915

• Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.

  International journal of pharmaceutics 20050914

• Dihydropyridines, felodipine, and PHARMAC.

  The New Zealand medical journal 20050715

• Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.

  Journal of periodontology 20050701

• Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.

  Drug development and industrial pharmacy 20050701

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Renoprotective therapy: is it blood pressure or albuminuria that matters?

  Lancet (London, England) 20050301

• Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

  Lancet (London, England) 20050301

• [The effect and mechanism of felodipine and valsartan on a novel salt-sensitive hypertensive rat induced by sensory denervation].

  Zhonghua xin xue guan bing za zhi 20050301

• Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres.

  Journal of microencapsulation 20050301

• Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients.

  Hypertension research : official journal of the Japanese Society of Hypertension 20050301

• Drug interactions with grapefruit juice.

  Obstetrics and gynecology 20050201

• Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050125

• Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects.

  European journal of clinical pharmacology 20050101

• Examination of 209 drugs for inhibition of cytochrome P450 2C8.

  Journal of clinical pharmacology 20050101

• Retrospective evaluation of a possible interaction between warfarin and levofloxacin.

  Pharmacotherapy 20050101

• [Toxicological analysis of selected 1,4-dihydropyridine calcium channel blockers in the diagnosis of intoxications].

  Archiwum medycyny sadowej i kryminologii 20050101

• Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.

  Scandinavian journal of clinical and laboratory investigation 20050101

• Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.

  Drugs 20050101

• Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment.

  Journal of the New Zealand Society of Periodontology 20050101

• Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans.

  Clinical pharmacology and therapeutics 20041201

• The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers.

  Endocrine 20041101

• [Gingival hyperplasia and calcium antagonists].

  Ugeskrift for laeger 20041018

• 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.

  Clinical pharmacology and therapeutics 20040601

• Nelfinavir and felodipine: a cytochrome P450 3A4-mediated drug interaction.

  Clinical pharmacology and therapeutics 20040401

• The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.

  American journal of hypertension 20040301

• Oxidation of Hantzsch 1,4-dihydropyridines of pharmacological significance by electrogenerated superoxide.

  Pharmaceutical research 20040301

• Determination of the lack of a drug interaction between azithromycin and warfarin.

  Pharmacotherapy 20040201

• [Nicergoline-induced Prinzmetal angina. 'Heartache' instead of headache].

  Orvosi hetilap 20040104

• Adherence to calcium channel blocker therapy in older adults: a comparison of amlodipine and felodipine.

  The Journal of international medical research 20040101

• [Efficacy and tolerability of felodipine based antihypertensive therapy in hospitalized patients with hypertension].

  Kardiologiia 20040101

• Calcium channel blockers (felodipine) and pediatric essential hypertension.

  Current hypertension reports 20031201

• Evaluation of a therapeutic conversion from amlodipine to felodipine.

  Pharmacotherapy 20031101

• Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine.

  Drug metabolism and disposition: the biological fate of chemicals 20030901

• Evaluation of polar lipid-hydrophilic polymer microparticles.

  International journal of pharmaceutics 20030827

• A comparative analysis of amlodipine and felodipine in a military outpatient population: efficacy, outcomes, and cost considerations.

  Military medicine 20030701

• Clinical trial of extended-release felodipine in pediatric essential hypertension.

  Pediatric nephrology (Berlin, Germany) 20030601

• Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA.

  Journal of the American Society of Nephrology : JASN 20030601

• Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.

  Clinical pharmacology and therapeutics 20030601

• Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension.

  Journal of internal medicine 20030401

• Can the USP paddle method be used to represent in-vivo hydrodynamics?

  The Journal of pharmacy and pharmacology 20030401

• Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension.

  Hypertension (Dallas, Tex. : 1979) 20030301

• [The effect of analysed hypotensive drugs on certain metabolic parameters].

  Polskie Archiwum Medycyny Wewnetrznej 20030301

• Sensitive spectrophotometric determination of amlodipine and felodipine using iron(III) and ferricyanide.

  Farmaco (Societa chimica italiana : 1989) 20030201

• [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].

  MMW Fortschritte der Medizin 20030123

• Different drug classes have variable effects on blood pressure depending on the time of day.

  American journal of hypertension 20030101

• The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs.

  Journal of clinical hypertension (Greenwich, Conn.) 20030101

• In vitro release of felodipine from original brand and generic products.

  Arzneimittel-Forschung 20030101

• Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study.

  Journal of clinical hypertension (Greenwich, Conn.) 20030101

• [Severe felodipine and theophylline poisoning successfully treated by 4-aminopyridine: a case report].

  Przeglad lekarski 20030101

• Chitosan microparticle preparation for controlled drug release by response surface methodology.

  Journal of microencapsulation 20030101

• Safety and efficacy of therapeutically equivalent doses of sustained-release formulations of isradipine and felodipine.

  Congestive heart failure (Greenwich, Conn.) 20030101

• Pharmacodynamic interactions of levosimendan and felodipine in patients with coronary heart disease.

  Cardiovascular drugs and therapy 20030101

• Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.

  The Canadian journal of cardiology 20021201

• Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR.

  Biochimica et biophysica acta 20021021

• Evaluation of controlled-release polar lipid microparticles.

  International journal of pharmaceutics 20020905

• Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.

  Clinical pharmacology and therapeutics 20020901

• Acute effects of vasoactive drug treatment on brachial artery reactivity.

  Journal of the American College of Cardiology 20020821

• Dihydropyridines are not substitutable without careful monitoring.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20020801

• [The effect and mechanism of felodipine on monocrotaline induced pulmonary hypertension in rats].

  Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20020801

• Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.

  Arteriosclerosis, thrombosis, and vascular biology 20020701

• A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension.

  American journal of hypertension 20020601

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism.

  American heart journal 20020401

• Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.

  The Journal of pharmacology and experimental therapeutics 20020301

• Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease.

  Journal of cardiovascular pharmacology 20020201

• A stability indicating LC method for felodipine.

  Journal of pharmaceutical and biomedical analysis 20020201

• Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20020115

• Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient.

  Transplantation 20020115

• Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth.

  Cardiovascular research 20020101

• Cutaneous drug reaction case reports: from the world literature.

  American journal of clinical dermatology 20020101

• Influence of hydrodynamics and particle size on the absorption of felodipine in labradors.

  Pharmaceutical research 20020101

• [Prospects of use of the combined preparation logimax in patients with essential hypertension].

  Terapevticheskii arkhiv 20020101

• Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients.

  The Journal of international medical research 20020101

• IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria.

  American journal of nephrology 20020101

• Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.

  Drugs & aging 20020101

• Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method.

  Journal of microencapsulation 20020101

• Influence of antihypertensive treatment with perindopril, pindolol or felodipinon plasma leptin concentration in patients with essential hypertension.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20020101

• Deleterious effects of nifedipine on smooth muscle cells implies alterations of intracellular calcium signaling.

  Fundamental & clinical pharmacology 20011201

• The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20011101

• One-year study of felodipine or placebo for stage 1 isolated systolic hypertension.

  Hypertension (Dallas, Tex. : 1979) 20011101

• Photodistributed felodipine-induced facial telangiectasia.

  Journal of the American Academy of Dermatology 20010801

• Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.

  Journal of human hypertension 20010801

• Reduction in diastolic blood pressure and cardiovascular mortality in nondiabetic hypertensive patients. A reanalysis of the HOT study.

  Arquivos brasileiros de cardiologia 20010801

• Polymorphism of racemic felodipine and the unusual series of solid solutions in the binary system of its enantiomers.

  Journal of pharmaceutical sciences 20010701

• [Felodipine in hypertensive patients with mild encephalopathies].

  Deutsche medizinische Wochenschrift (1946) 20010511

• Investigation of the felodipine glassy state by atomic force microscopy.

  International journal of pharmaceutics 20010507

• Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.

  The American journal of cardiology 20010315

• Mechanism of CGRP-induced relaxation in rat intramural coronary arteries.

  British journal of pharmacology 20010301

• [Letter concerning the article by E.C.Bornhövd, E.Schuller, T.Bieber, A.Wollenberg: 'Immunosuppressive macrolides and their use in dermatology'. Der Hautarzt (2000) 51:646-654].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20010301

• Normal-phase TLC separation of enantiomers of 1.4-dihydropyridine derivatives.

  Drug development and industrial pharmacy 20010201

• Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.

  Clinical pharmacology and therapeutics 20010101

• Comparison of the time courses and potencies of the vasodilator effects of nifedipine and felodipine in the human forearm.

  Blood pressure 20010101

• A randomised trial to compare the efficacy and safety of Felodipine (Plendil) and Nifedipine (Adalat) retard in patients with mild-to-moderate hypertension.

  West African journal of medicine 20010101

• Stroke precipitated by moderate blood pressure reduction.

  The Journal of emergency medicine 20001101

• Losartan: a review of its use, with special focus on elderly patients.

  Drugs & aging 20000301

• Low Dose Combination Therapy vs. High Dose Monotherapy in the Management of Hypertension.

  Journal of clinical hypertension (Greenwich, Conn.) 19991101

• Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study Group.

  International journal of clinical practice 19980901

• Significance of blood pressure levels achieved with felodipine anti-hypertensive treatment on cardiovascular structure and function changes.

  Journal of human hypertension 19980701

• A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension.

  International journal of clinical practice 19980601

• Benazepril versus felodipine as supplement to bendroflumethiazide: evaluation by office and ambulatory blood pressure.

  Blood pressure monitoring 19980401

• Prevention of left ventricular hypertrophy by ACE-inhibitor, ramipril in comparison with calcium-channel antagonist, felodipine.

  International journal of cardiology 19980131

• Influence of felodipine on experimental seizures and activity of different antiepileptic drugs in mice.

  Polish journal of pharmacology 19980101

• Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.

  Circulation 19970805

• Verapamil accelerates the transition to heart failure in obese, hypertensive, female SHHF/Mcc-fa(cp) rats.

  Journal of cardiovascular pharmacology 19970601

• Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.

  British journal of pharmacology 19970501

• Calcium antagonists, a useful additional therapy in treatment resistant hypertension: comparison of felodipine ER and nifedipine Retard by 24-h ambulatory blood pressure monitoring.

  The Netherlands journal of medicine 19970101

• Felodipine in the treatment of severe refractory hypertension.

  Journal of human hypertension 19960901

• Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.

  Drugs 19960501

• Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function?

  Scandinavian journal of urology and nephrology 19960201

• Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.

  Blood pressure. Supplement 19960101

• Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 19950701

• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.

  The American journal of cardiology 19950415

• Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.

  Drugs 19950401

• Mono- and combination therapy with felodipine or enalapril in elderly patients with systolic hypertension.

  Blood pressure 19940301

• Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.

  Clinical therapeutics 19940101

• Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension.

  The American journal of cardiology 19931001

• General toxicity of the new calcium antagonist felodipine in dogs.

  Arzneimittel-Forschung 19930701

• A multicenter comparison of isradipine and felodipine in the treatment of mild-to-moderate hypertension. The Physician's Study Group.

  American journal of hypertension 19930301

• Long-term effects of felodipine in patients with reduced renal function.

  Kidney international. Supplement 19920501

• Felodipine clinical pharmacokinetics.

  Clinical pharmacokinetics 19911201

• Felodipine: a new dihydropyridine calcium-channel antagonist.

  DICP : the annals of pharmacotherapy 19911101

• Beta-adrenergic receptors and reflex tachycardia after single and repeated felodipine administration in essential hypertension.

  Journal of cardiovascular pharmacology 19910601

• Felodipine in combination with a beta-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. The Australian Felodipine Multicentre Study Group.

  European journal of clinical pharmacology 19910101

• Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording.

  American journal of hypertension 19910101

• Acute effects on exercise tolerance of felodipine and diltiazem, alone and in combination, in stable effort angina.

  European heart journal 19910101

• Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo.

  British journal of clinical pharmacology 19901001

• The influence of infusion rate on the hemodynamic effects of felodipine.

  Clinical pharmacology and therapeutics 19900901

• The efficacy and tolerability of long-term felodipine treatment in hypertension. The Scandinavian Multicenter Group.

  Cardiovascular drugs and therapy 19900601

• Cardiovascular-risk reduction: initial diuretic therapy compared with calcium-antagonist (felodipine) therapy for primary hypertension.

  The Medical journal of Australia 19890904

• Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

  Drugs 19881001

• Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy.

  Journal of cardiovascular pharmacology 19880701

• A double-blind comparison of felodipine and hydrochlorothiazide added to metoprolol to control hypertension.

  European journal of clinical pharmacology 19880101

• Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension.

  Journal of cardiovascular pharmacology 19871001

• Monotherapy with felodipine, a new calcium antagonist, in mild and moderate hypertension.

  Journal of cardiovascular pharmacology 19870101

• Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.

  Drugs 19870101

• Baroreflex control of renin release in spontaneously hypertensive rats after administration of felodipine.

  Drugs 19870101

• Felodipine compared to nifedipine as 'third-line drug' in resistant hypertension.

  Angiology 19861101

• Renal and antihypertensive effects of felodipine in hypertensive patients.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 19851201

• Felodipine can replace minoxidil in the treatment of refractory hypertension.

  Journal of hypertension. Supplement : official journal of the International Society of Hypertension 19851201

• Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR.

  European journal of pharmacology 19850711

• Antihypertensive effect of felodipine combined with beta-blockade. A comparison between 2 and 3 daily dosages.

  Drugs 19850101

• Comparative trial of felodipine and nifedipine in refractory hypertension.

  Drugs 19850101

• Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension.

  Drugs 19850101

• Haemodynamic effects of single-dose felodipine in normal man.

  Drugs 19850101

• Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.

  The American journal of cardiology 19830901